What this means
This is a trial that is still recruiting people, and no results have been posted yet. It will test whether a gut bacteria supplement changes signs of biological aging.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 40–75
- Where
- 1 site, including Florida
The science
- Registered title
- iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults
- Trial ID
- NCT07407894 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Healthy Aging, Anti Aging
- What is tested
- Bifidobacterium adolescentis iVS-1, Placebo
- Sponsor
- Synbiotic Health
- Ages
- 40 Years to 75 Years
- Dates
- First posted Feb 12, 2026 · updated Apr 22, 2026
Registry summary
This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.
Sites (1)
- MusB Research LLC, New Port Richey, Florida, United States